Rheumatoid arthritis affects millions of Americans, gradually changing lives as it progresses from subtle joint discomfort to potentially severe mobility limitations. For those living with this ...
Please provide your email address to receive an email when new articles are posted on . As highlighted in recent advances in rheumatoid arthritis pathogenesis, researchers’ understanding of the ...
Preclinical rheumatoid arthritis, also known as pre-rheumatoid arthritis (pre-RA), represents the phase of rheumatoid arthritis (RA) development before symptoms appear, i.e., before inflammatory ...
NEW YORK, Nov 7 Reuters) - A closely watched experimental drug for rheumatoid arthritis being developed by Pfizer Inc significantly reduced symptoms and improved physical function, according to data ...
Making the diagnosis of RA was not problematic in this patient, because she had been diagnosed with seropositive RA early in her case history. The challenge was to correctly stage the disease ...
With the discovery of autoantibodies and other risk factors for rheumatoid arthritis (RA), researchers developed clinical trials to see whether the disease can be prevented entirely. In the past 10 ...
A groundbreaking scientific perspective is reshaping how researchers understand rheumatoid arthritis, a debilitating autoimmune condition that affects nearly 1.3 million Americans. Recent studies have ...
Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...
BOSTON, Nov. 7 (Reuters) - Swiss drugmaker Roche Holding AG said on Wednesday that its experimental rheumatoid arthritis drug, Actemra, was effective in the second of five late-stage clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback